RYCBX | RYURX | RYCBX / RYURX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 31 years | - |
Gain YTD | 4.123 | 2.701 | 153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | 1000 | 1000 | 100% |
Net Assets | 10.6M | 38.8M | 27% |
Annual Yield % from dividends | 4.79 | 3.02 | 159% |
Returns for 1 year | -24.10 | -11.20 | 215% |
Returns for 3 years | -51.45 | -23.61 | 218% |
Returns for 5 years | -86.05 | -56.19 | 153% |
Returns for 10 years | -95.64 | -73.41 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 71.89 | 1.10 | +1.55% |
Janus Henderson Global Life Sciences D | |||
QASGX | 24.17 | 0.26 | +1.09% |
Federated Hermes MDT Small Cap Growth A | |||
NESIX | 17.73 | N/A | N/A |
Needham Small Cap Growth Institutional | |||
BSVAX | 10.19 | N/A | N/A |
BlackRock Sustainable US Value Eq Inv A | |||
GSPUX | 38.86 | N/A | N/A |
Goldman Sachs Large Cap Core R6 |